The ProPep system is specifically designed for use during robotic surgery. It is intended to allow surgeon to do intraoperative nerve monitoring during minimally invasive, robotic-assisted surgery for prostate cancer.
The system helps surgeons make a more informed decision about which nerve tissue to selectively preserve or remove during an operation, and also assess the integrity of the nerve during the procedure, according to the release.
ProPep Surgical is headquartered in Austin, Texas.
Related Articles on FDA Clearances:
Ultrasonix Medical Receives FDA Approval for Needle Guidance Technology
Synergetics Receives FDA Clearance for Versavit Vitrectomy System
FDA Approves First Glaucoma Stent for Cataract Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.